Effect of Low-Dose Oral Etoposide on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By de Jong R.S.   Hofstra L.S.   Willemse P.H.B.   de Bruijn H.W.A.   de Vries E.G.E.   Boonstra H.   Mulder N.H.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 197-201

Elsevier

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T.   Marth C.   Kaern J.   Nustad K.   Kristensen G.B.   Trope C.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite

Serum CA-125 Screening for Ovarian Cancer in Patients with Dermatomyositis

By Whitmore S.E.   Anhalt G.J.   Provost T.T.   Zacur H.A.   Hamper U.M.   Helzlsouer K.J.   Rosenshein N.B.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 241-244

Elsevier

Access to resources Recommend Favorite

The Relationship between Postoperative Decline of Serum CA 125 Levels and Size of Residual Disease after Initial Surgery in Patients with Advanced Ovarian Cancer: A CTF Study

By Gadducci A.   Landoni F.   Maggino T.   Sartori E.   Zola P.   Fanucchi A.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 234-237

Academic Press

Access to resources Recommend Favorite

Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?

By Saygili U.   Guclu S.   Uslu T.   Erten O.   Demir N.   Onvural A.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 57-61

Academic Press

Access to resources Recommend Favorite